Clinical trials of one of most promising candidate vaccines suspended after patient develops unexplained illness.
Vinicius Molla, a haematologist and volunteer in the clinical trial of the Oxford COVID-19 vaccine, examines a patient in a consulting room in Sao Paulo, Brazil [File: Amanda Perobelli/Reuters]
- AstraZeneca says it has suspended trials of the coronavirus vaccine it is developing with the University of Oxford after one of the trials’ volunteers fell ill with an unexplained illness.
- The UN says the disruption to routine child and maternal health services as a result of the pandemic could put millions of lives at risk and undo years of progress in reducing child mortality.
- More than 27.5 million people around the world have been diagnosed with the coronavirus and 897,383 have died. More than 18.5 million people have recovered.
- Also read Osun Records 19 New Cases Of Coronavirus, Discharges 10 Patients
